| Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool in Screening Older Adults for Unhealthy Substance Use BH Han, JJ Palamar, AA Moore, RP Schwartz, LT Wu, G Subramaniam, ... Journal of Addiction Medicine, 10.1097, 2024 | | 2024 |
| Long-Term Mortality After Drug Use-Associated Endocarditis is High and Differs by Race and Sex: Results of a Statewide Study A Schranz, M Figgatt, V Chu, LT Wu, D Rosen Drug and Alcohol Dependence 260, 110566, 2024 | | 2024 |
| Leveraging Behavioral Interventions to Support People with Chronic Pain L McCormack, M Edlund, P Chelminski, L Wu, K Archer, S Thomas, ... 2024 Annual Research Meeting, 2024 | | 2024 |
| Long-term risk of serious infections and mortality among patients surviving drug use-associated infective endocarditis MC Figgatt, DL Rosen, VH Chu, LT Wu, AJ Schranz Clinical Infectious Diseases, ciae214, 2024 | | 2024 |
| Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus AJ Rush, RE Gore-Langton, G Bart, KA Bradley, CI Campbell, J McKay, ... Addiction Science & Clinical Practice 19 (1), 14, 2024 | | 2024 |
| Design of a Multicenter Randomized Controlled Trial comparing the effectiveness of shared decision making versus motivational interviewing plus cognitive behavioral therapy for … MJ Edlund, SM Thomas, LK Wagner, JE Thompson, LT Wu, RJ Dolor, ... Contemporary Clinical Trials 137, 107410, 2024 | | 2024 |
| Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods JM Liebschutz, GA Subramaniam, R Stone, N Appleton, L Gelberg, ... Addiction science & clinical practice 18 (1), 70, 2023 | | 2023 |
| Research priorities for expansion of opioid use disorder treatment in the community pharmacy JB Jarrett, J Bratberg, AL Burns, G Cochran, BA DiPaula, A Legreid Dopp, ... Substance abuse 44 (4), 264-276, 2023 | 4 | 2023 |
| Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff LT Wu, P Mannelli, WS John, A Anderson, RP Schwartz Substance abuse treatment, prevention, and policy 18 (1), 55, 2023 | 1 | 2023 |
| Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the US LT Wu, WS John, P Mannelli, ED Morse, A Anderson, RP Schwartz Addiction science & clinical practice 18 (1), 45, 2023 | 2 | 2023 |
| A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool AM Bunting, RP Schwartz, LT Wu, A Wahle, M Kline, G Subramaniam, ... Journal of addiction medicine 17 (4), 471-473, 2023 | 1 | 2023 |
| The impact of discharge against medical advice on readmission after opioid use disorder-associated infective endocarditis: a national cohort study AJ Schranz, C Tak, LT Wu, VH Chu, DA Wohl, DL Rosen Journal of general internal medicine 38 (7), 1615-1622, 2023 | 4 | 2023 |
| Development and validation of an electronic health records‐based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids SI Ranapurwala, IZ Alam, BW Pence, TS Carey, S Christensen, M Clark, ... Pharmacoepidemiology and drug safety 32 (5), 577-585, 2023 | 9 | 2023 |
| Assessing the impact of COVID-19 on the health of Native Hawaiian/Pacific Islander people in the United States, 2021 AM Subica, N Aitaoto, Q Li, BN Morey, LT Wu, DK Iwamoto, EG Guerrero, ... Public Health Reports 138 (1), 164-173, 2023 | 10 | 2023 |
| Research priorities for expanding access to methadone treatment for opioid use disorder in the united states: a national institute on drug abuse clinical trials network task … PJ Joudrey, G Bart, RK Brooner, L Brown, J Dickson-Gomez, A Gordon, ... SUBSTANCE ABUSE 43 (1), 691-691, 2022 | 2 | 2022 |
| Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID‐19 AM Subica, EG Guerrero, TKK Martin, SK Okamoto, N Aitaoto, HB Moss, ... Drug and alcohol review 41 (7), 1653-1663, 2022 | 9 | 2022 |
| Alcohol use disorder risk and protective factors and associated harms among Pacific Islander young adults AM Subica, EG Guerrero, P Hong, N Aitaoto, HB Moss, DK Iwamoto, ... Journal of racial and ethnic health disparities 9 (5), 1818-1827, 2022 | 3 | 2022 |
| The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study NS Karnik, J Marsden, C McCluskey, RA Boley, KA Bradley, CI Campbell, ... Addiction 117 (9), 2438-2447, 2022 | 13 | 2022 |
| Mifepristone (RU-486®) as a Schedule IV Controlled Drug—Implications for a Misleading Drug Policy on Women’s Health Care YP Hsieh, YJ Wang, LY Feng, LT Wu, JH Li International journal of environmental research and public health 19 (14), 8363, 2022 | | 2022 |
| Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability RK Brooner, KB Stoller, P Patel, LT Wu, H Yan, M Kidorf Drug and alcohol dependence reports 3, 100067, 2022 | 8 | 2022 |
